ESC Premium Access

Empagliflozin improves cardiac function through the increased production of acetylcarnitine in a murine non-diabetic heart failure model

Presentation

About the speaker

Doctor Masaaki Nakao

Niigata University Graduate School of Medical and Dental Sciences, Niigata (Japan)
0 follower

11 more presentations in this session

Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity

Speaker: Doctor S. Tual-Chalot (Newcastle upon Tyne, GB)

Thumbnail

Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction

Speaker: Doctor G. Vilahur (Barcelona, ES)

Thumbnail

Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness

Speaker: Associate Professor G. De Luca (Novara, IT)

Thumbnail

Carvedilol and its analogue VK-II-86 attenuate stretch-induced manifestations of mechanoelectric feedback.

Speaker: Miss I. Del Canto Serrano (Valencia, ES)

Thumbnail

Access the full session

Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

Speakers: Doctor M. Nakao, Professor I. Andreadou, Doctor S. Tual-Chalot, Doctor G. Vilahur, Associate Professor G. De Luca...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk